An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation

NCT06466486 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
310
Enrollment
INDUSTRY
Sponsor class

Stopped This is a company decision made not related to safety concerns. Rather, it reflects a broader portfolio assessment and the desire to focus on programs that can bring timely and meaningful benefit to patients.

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals